CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $82,244
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$82,244. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-06-22 | Runge Jeffrey W. Director | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2012-06-22 | McCleary Joel Director | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2012-06-22 | MARKISON BRIAN A Director | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2012-06-22 | GILL JOHN Director | Grant or award · Stock option (right to buy) | +20,000 | 20,000 | ||
| 2012-03-07 | RICHMAN ERIC I See Remarks | Shares withheld for taxes | −22,500 | 176,822 |
Page 43 of 43 · 845 trades